BEAMSTART Logo

HomePeopleProfile

Andrew Kruegel

Founder, Gilgamesh Pharmaceuticals 


Join Date

October 2024

Gender

Not Specified

Age

Not Specified


About Andrew Kruegel

I am a medicinal chemist, pharmacologist, and entrepreneur with extensive experience in the design and preclinical development of psychoactive drugs for the future treatment of psychiatric illnesses. In the context of my entrepreneurial endeavors I have also built significant expertise in business, fundraising, operations, and intellectual property strategy.

Companies & Work

Gilgamesh Pharmaceuticals

Gilgamesh Pharmaceuticals

Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise. We are an experienced team, with proven success in biotech exits and inventions.

Share This Profile

Featured Members from United States

Connor Janson

Co-founder of BidSight

Jayesh K.

Founder, Silurian

Mohamed Eltayib

CEO of ZA Group

Ben Stein

Founder, Keeper

Grenard Madrigal

Co-founder of RocketLit

Vikas Nair

Founder, Openlayer

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2024 BEAMSTART. All Rights Reserved.